Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma. (Q34658095)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma. |
scientific article |
Statements
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma (English)
Thomas E Hutson
Ho Yeong Lim
Kenneth B Pittman
Peggy Senico
Andreas Niethammer
Dongrui Ray Lu
Subramanian Hariharan